학술논문

Right in Front of Our Eyes: Evolution of Streptococcal Toxic Shock Syndrome with Ischemic Optic Neuropathy.
Document Type
Case Study
Source
Rhode Island Medical Journal. Dec2016, Vol. 99 Issue 12, p47-49. 3p.
Subject
*TOXIC shock syndrome
*NEUROLOGICAL disorders
*THERAPEUTICS
*STREPTOCOCCUS
*SEPTIC shock treatment
*NEUROPATHY
*DISEASE risk factors
Language
ISSN
0363-7913
Abstract
Toxic shock syndrome occurs from dysregulation of host inflammatory responses. Toxinproducing strains of Group A streptococcus cause TSS. Ischemic optic neuropathy rarely complicates septic shock. We present a rare case of streptococcal pharyngitis complicated by septic arthritis and TSS with reversible blindness due to non-arteritic ischemic optic neuropathy. Case: A 28-year-old man drove to our ED with exudative pharyngitis. A rapid streptococcal test was positive. While awaiting oral penicillin he became hypotensive refractory to IV fluids and developed knee effusion. The patient noted progressive dimming of his vision. Arthrocentesis yielded GAS. ICU course was complicated by ARDS but after 2 weeks the patient was weaned off vasopressors and the ventilator. He regained his vision and had no neurological sequelae. The patient's GAS isolate was M protein gene (emm) type 1 and T type 1. He was followed in the IM clinic for 9 months post discharge with complete resolution of symptoms. Conclusion: The rapidity of the development of shock is attributed to streptococcal exotoxins acting as superantigens. GAS type M1 is commonly associated with severe shock in TSS. The severe shock was the likely cause of his ischemic optic neuropathy. Early recognition and aggressive management of TSS are crucial to clinical outcome. [ABSTRACT FROM AUTHOR]